Key result
Systemic lupus erythematosus linked to ~2.2-fold higher odds of obstructive CAD vs. matched controls.
Why the study?
Does systemic lupus erythematosus increase the likelihood of angiographically defined obstructive coronary artery disease and all-cause mortality in patients undergoing cardiac catheterization for suspected CAD?
Cohort (n=344)
No
Does systemic lupus erythematosus increase the likelihood of angiographically defined obstructive coronary artery disease and all-cause mortality in patients undergoing cardiac catheterization for suspected CAD?
Answers are grounded in this paper and cite their sources.
Patients with SLE referred for coronary angiography had over twice the risk-adjusted odds of obstructive CAD and comparable angiographic disease severity as matched controls despite being a median of 21 years younger and having lower rates of diabetes and hyperlipidemia.
OBJECTIVE: To determine if systemic lupus erythematosus (SLE) is associated with a higher prevalence of coronary artery disease (CAD) in select patients undergoing coronary angiography. We compared the extent of angiographic abnormalities, CAD risk factors, and all-cause mortality in SLE patients with non-SLE controls. METHODS: We identified SLE patients (n = 86) and controls matched by sex and year of cardiac catheterization (n = 258) undergoing cardiac catheterization for the evaluation of CAD (median followup duration of 4.3 years). Multivariable logistic regression was used to determine if SLE was associated with obstructive CAD, defined as ≥70% stenosis in a major epicardial coronary artery. Risk-adjusted survival differences between the 2 groups were assessed using Cox proportional hazards modeling. RESULTS: The SLE patients (85% women) were younger than the non-SLE patients (median age 49 years versus 70 years; P < 0.001) and were less likely to have diabetes mellitus and hyperlipidemia, but had similar rates of hypertension (70% versus 71%; P = 0.892). In unadjusted analyses, SLE and non-SLE patients had similar rates of obstructive CAD by angiography (52% versus 62%; overall P = 0.11). After adjustment for known CAD risk factors, SLE was associated with a significantly increased likelihood of CAD (odds ratio 2.24 [95% confidence interval (95% CI) 1.08-4.67]). SLE was also associated with a nonsignificant increase in all-cause mortality (hazard ratio 1.683 [95% CI 0.98-2.89], P = 0.060). CONCLUSION: In this selected population, SLE was significantly associated with the presence of CAD as defined by coronary angiography, the gold standard for assessing flow-limiting lesions in this disease. The patients with SLE showed a similar severity of CAD as the controls despite having less than half the rate of diabetes mellitus and being 20 years younger.
No takes yet. Share an insight, caveat, or question.
Kaul et al. (2012) conducted a cohort in Suspected coronary artery disease in patients with and without systemic lupus erythematosus (n=344). Systemic lupus erythematosus (SLE) vs. Non-SLE controls matched 3:1 by sex and year of cardiac catheterization was evaluated on Obstructive coronary artery disease (defined as >=70% stenosis in at least one major epicardial coronary artery on coronary angiography) (OR 2.24, 95% CI 1.08-4.67, p=0.03). Systemic lupus erythematosus was associated with an increased likelihood of angiographic obstructive CAD after risk-factor adjustment vs matched controls.
Synapse has enriched 10 related papers. Consider them for comparative context: